Colgate-Palmolive (CL) Stock Forecast & Price Target

$87.66 +0.65 (+0.74%)

Closing price 09/17/2026 03:59 PM Eastern

Extended Trading

$87.70 +0.03 (+0.04%)

As of 06:17 AM Eastern

Compare

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
6

Buy
13

Based on 19 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 6 have given a hold rating, and 13 have given a buy rating for CL.

Consensus Price Target

$99.00
12.93% Upside

According to the 19 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $99.00. The highest price target for CL is $110.00, while the lowest price target for CL is $87.00. The average price target represents a forecasted upside of 12.93% from the current price of $87.67.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

Type	Current Forecast 9/18/25 to 9/18/26	1 Month Ago 8/19/25 to 8/19/26	3 Months Ago 6/20/25 to 6/20/26	1 Year Ago 9/18/24 to 9/18/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	7 Buy rating(s)
Hold	6 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$99.00	$99.00	$95.88	$98.00
Forecasted Upside	12.93% Upside	8.86% Upside	6.84% Upside	20.07% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	Broader Market
Consensus Rating Score	2.68	2.22	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	12.93% Upside	157.08% Upside	17.73% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/16/2026	Weiss Ratings 5 of 5 stars		Upgrade	Hold (C+) ➝ Buy (B-)
9/8/2026	Royal Bank Of Canada 3 of 5 stars	Nik Modi 2 of 5 stars	Reiterated Rating	Outperform	$104.00	+17.54%
8/13/2026	Sanford C. Bernstein 3 of 5 stars	Cristian Rios Not Rated	Reiterated Rating	Market Perform
8/3/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$101.00	+10.42%
8/3/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$104.00	+12.06%
8/3/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$106.00 ➝ $109.00	+17.45%
8/3/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Moskow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$85.00 ➝ $90.00	-3.03%
8/3/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
8/3/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$104.00 ➝ $103.00	+12.67%
7/21/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$80.00 ➝ $87.00	-5.36%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
7/14/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$105.00 ➝ $110.00	+18.09%
7/9/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$92.00 ➝ $96.00	+3.11%
7/8/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$92.00 ➝ $95.00	-0.05%
5/1/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
4/21/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Neutral ➝ Buy	$93.00 ➝ $100.00	+19.78%
4/10/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Spillane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$105.00 ➝ $102.00	+18.58%
2/2/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Ottenstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$94.00 ➝ $100.00	+10.76%
12/11/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor Conrad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
10/20/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Tong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$105.00 ➝ $95.00	+20.01%
2/3/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$95.00 ➝ $93.00	+7.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:18 AM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 17, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive is currently trading at $87.67, which is significantly below the consensus price target of $99.00 held by sell-side analysts, suggesting potential upside for investors who believe the market is undervaluing the company's recovery trajectory.
The company has declared a quarterly cash dividend of $0.53 per share, payable on November 13, 2026, maintaining its status as a Dividend King with uninterrupted dividend payments since 1895, which provides a stable income stream with a current yield of 2.44%.
Recent earnings reports show consistent outperformance, with the company beating consensus estimates in the most recent quarter by reporting $0.99 in earnings per share against an expected $0.95, while also achieving 4.9% year-over-year revenue growth, indicating strong operational resilience.
Reports indicate that Colgate-Palmolive is exploring the sale of certain mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, a strategic move that could streamline the portfolio and potentially generate significant capital to reinvest in core growth areas or reduce debt.
Institutional investors are showing renewed confidence, with Bank of America Corp DE purchasing a new stake of approximately $567 million in the second quarter, and other major funds like Geode Capital Management and Bank of New York Mellon increasing their positions, signaling broad market support for the stock.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

The stock is trading at a price-to-earnings ratio of 34.79, which is relatively high for a consumer staples company, suggesting that the current valuation may not leave much room for error if growth expectations are not met in the coming quarters.
Corporate insiders have been actively selling shares, with the Chief Operating Officer selling 10,000 shares in August 2026 and the CEO selling over 161,000 shares in early August, a trend that can signal a lack of confidence in the short-term stock price from those closest to the company's operations.
Colgate-Palmolive is facing legal and regulatory headwinds, including a judge setting a trial date for a lawsuit regarding the recyclability of its toothpaste tubes, which could result in costly litigation or mandatory changes to packaging that affect margins.
The company is increasing advertising spend to revive North America growth, which may pressure near-term profitability as it attempts to stimulate demand in a challenging market environment, potentially offsetting the benefits of its recent revenue growth.
Short interest has remained relatively elevated, with approximately 17.17 million shares shorted as of the most recent record date, indicating that a significant portion of the market is betting against the stock's performance, which can create volatility and downward pressure on the share price.

CL Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $99.00, with a high forecast of $110.00 and a low forecast of $87.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 12.93% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 1 upgrade by analysts.

Colgate-Palmolive has been rated by research analysts at Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

MarketBeat monitors more than a dozen sources for Colgate-Palmolive analyst ratings, with the most recent rating issued on 9/16/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case

CL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CL Analyst Ratings Over Time

CL Analyst Recommendations By Month

CL Price Targets by Month

Colgate-Palmolive Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Colgate-Palmolive Bull Case

Colgate-Palmolive Bear Case

CL Forecast - Frequently Asked Questions

What is Colgate-Palmolive's forecast for 2026?

Should I buy or sell Colgate-Palmolive stock right now?

Does Colgate-Palmolive's stock price have much upside?

Has Colgate-Palmolive been upgraded by Wall Street analysts recently?

What analysts cover Colgate-Palmolive?

Do Wall Street analysts like Colgate-Palmolive more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Colgate-Palmolive Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Colgate-Palmolive
Bull Case

Colgate-Palmolive
Bear Case